Trial record 1 of 2 for:    Leukine and Alzheimer's disease
Previous Study | Return to List | Next Study

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by University of Colorado, Denver
Sponsor:
Collaborator:
The Dana Foundation
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01409915
First received: August 2, 2011
Last updated: August 7, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)